Anlon Healthcare Ltd vs Vinyl Chemicals I Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 25, 2026

Key Highlights

The Latest Trading Price of Anlon Healthcare Ltd is ₹ 115.65 as of 25 Mar 10:12 . The P/E Ratio of Anlon Healthcare Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Vinyl Chemicals (I) Ltd changed from 18.7 on March 2021 to 23.2 on March 2025 . This represents a CAGR of 4.41% over 5 years The Market Cap of Anlon Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Vinyl Chemicals (I) Ltd changed from ₹ 212.71 crore on March 2021 to ₹ 518.57 crore on March 2025 . This represents a CAGR of 19.51% over 5 years The revenue of Anlon Healthcare Ltd for the Dec '25 is ₹ 35.78 crore as compare to the Sep '25 revenue of ₹ 52.23 crore. This represent the decline of -31.5% The revenue of Vinyl Chemicals (I) Ltd for the Dec '25 is ₹ 171.96 crore as compare to the Sep '25 revenue of ₹ 153.16 crore. This represent the growth of 12.27% The ebitda of Anlon Healthcare Ltd for the Dec '25 is ₹ 12.54 crore as compare to the Sep '25 ebitda of ₹ 13.77 crore. This represent the decline of -8.93% The ebitda of Vinyl Chemicals (I) Ltd for the Dec '25 is ₹ 6.19 crore as compare to the Sep '25 ebitda of ₹ 3.94 crore. This represent the growth of 57.11% The net profit of Anlon Healthcare Ltd changed from ₹ 4.54 crore to ₹ 5.15 crore over 7 quarters. This represents a CAGR of 7.47% The net profit of Vinyl Chemicals (I) Ltd changed from ₹ 4.92 crore to ₹ 4.52 crore over 7 quarters. This represents a CAGR of -4.73% The Dividend Payout of Anlon Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Vinyl Chemicals (I) Ltd changed from 60.46 % on March 2021 to 57.37 % on March 2025 . This represents a CAGR of -1.04% over 5 years .

About Anlon Healthcare Ltd

Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 issued by the RoC. The Company changed the name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh Certificate of Incorporation dated May 27, 2015 was issued by the RoC. The status of the Company was subsequently converted to a Public Limited and the name of the Company was changed to 'Anlon Healthcare Limited' dated September 2, 2024 by the RoC. Anlon Healthcare is engaged in manufacturing of Pharma Intermediates and APIs.
They are one of the few manufacturers of loxoprofen sodium dihydrate in India, a notable API , widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction.

About Vinyl Chemicals (I) Ltd

Incorporated in 1986, Vinyl Chemicals (I) Limited is dealing in chemicals, mainly Vinyl Acetate Monomer (VAM).
It was promoted by the Parekh Group - a well-known group which manufactures and sells the Fevicol brand of adhesives, synthetic resins, binders, surfactants, pigments, etc - and SICOM, a Government of Maharashtra enterprise.
The Company is engaged mainly in trading of Vinyl Acetate Monomer. Uhde Gmbh, Germany, (a subsidary of Hoechst) has provided the technology for manufacturing Vinyl Acetate Monomer.
Apart from providing technology the German colloborator provided basic engineering services and trained personnel for errection and start-up activities. This is the first company to manufacture VAM directly from petrochemical ethylene.
VAM is a versatile petrochemical used in the manufacture of polyvinyl acetate, polyvinyl alchohol, ethylene vinyl acetate co-polymers, vinyl acrylic co-polymers, acrylic fibres, etc.

FAQs for the comparison of Anlon Healthcare Ltd and Vinyl Chemicals (I) Ltd

Which company has a larger market capitalization, Anlon Healthcare Ltd or Vinyl Chemicals (I) Ltd?

Market cap of Anlon Healthcare Ltd is 597 Cr while Market cap of Vinyl Chemicals (I) Ltd is 342 Cr

What are the key factors driving the stock performance of Anlon Healthcare Ltd and Vinyl Chemicals (I) Ltd?

The stock performance of Anlon Healthcare Ltd and Vinyl Chemicals (I) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anlon Healthcare Ltd and Vinyl Chemicals (I) Ltd?

As of March 25, 2026, the Anlon Healthcare Ltd stock price is INR ₹112.35. On the other hand, Vinyl Chemicals (I) Ltd stock price is INR ₹187.0.

How do dividend payouts of Anlon Healthcare Ltd and Vinyl Chemicals (I) Ltd compare?

To compare the dividend payouts of Anlon Healthcare Ltd and Vinyl Chemicals (I) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.